2009 discharge: European Medicines Agency (EMEA)

PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2009, as part of the 2009 discharge procedure.

Analysis of the accounts of the European Medicines Agency (EMEA).

CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2009 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 129 (2) of the Financial Regulation applicable to the EU’s General Budget, including the European Medicines Agency (EMEA).

In 2009, the tasks and budget of this agency were as follows:

·         description of the Agency’s tasks: the European Medicines Agency, which is located in London, was created by Council Regulation (EEC) No 2309/93, which was replaced by Regulation (EC) No 726/2004 of the European Parliament and of the Council. The Agency operates through a network and coordinates the scientific resources made available by the national authorities in order to ensure the evaluation and supervision of medicinal products for human or veterinary use.

·         The Agency’s budget for the 2009 financial year:the Agency’s 2009 budget amounted to EUR 194.4 million, compared with EUR 182.9 million the previous year. The number of staff employed by the Agency at the end of the year was 664, as compared with 587 the previous year.

The complete version of the Agency’s final accounts may be found at the following address: http://www.ema.europa.eu